Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospektive, Randomisierte Doppelblinde Studie Zur Dosisfindung Von Intestinal Redardiert Freigesetztem Phosphatidylcholin Bei Chronisch Aktiver Pancolitis Ulcerosa

NCT00259558 is registered in ClinicalTrials.gov with Heidelberg University as lead sponsor.

NCT NCT00259558
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00259558 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospektive, Randomisierte Doppelblinde Studie Zur Dosisfindung Von Intestinal Redardiert Freigesetztem Phosphatidylcholin Bei Chronisch Aktiver Pancolitis Ulcerosa
Lead sponsor
Heidelberg University
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2003
Completion date
March 31, 2006
Enrollment
60
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis